Histone demethylase JMJD3 at the intersection of cellular senescence and cancer

Area of Science:

• Epigenetics and Cellular Biology
• Cancer Biology and Tumor Suppression
• Aging and Regenerative Medicine

Background:

• Cellular senescence is a key tumor suppressor mechanism characterized by irreversible growth arrest.
• Cancer cells can evade senescence through DNA mutations, but epigenetic contributions remain largely unexplored.
• Histone modifications and chromatin remodeling, particularly involving the jumonji domain-containing protein 3 (JMJD3; also known as KDM6B), are vital in various biological processes including senescence.

Purpose of the Study:

• To investigate the poorly understood role of JMJD3 (KDM6B) in cancer development and its link to senescence.
• To explore how epigenetic factors, specifically JMJD3, contribute to cancer cells escaping senescence.
• To understand JMJD3's potential role at the intersection of cancer pathways and the senescence-associated secretory phenotype (SASP).

Main Methods:

• Analysis of histone modifications and chromatin remodeling associated with JMJD3 (KDM6B) function.
• Investigating the impact of JMJD3 on cellular senescence and tumor suppression.
• Examining the relationship between JMJD3, cancer cell escape from senescence, and SASP activation.

Main Results:

• JMJD3 (KDM6B) plays a significant role in epigenetic regulation impacting cellular senescence.
• Dysfunctional pathways involving JMJD3 may enable cancer cells to bypass senescence.
• JMJD3's function is implicated in the activation of the senescence-associated secretory phenotype (SASP).

Conclusions:

• JMJD3 (KDM6B) is a critical epigenetic regulator in cellular senescence and aging.
• Understanding JMJD3's role in cancer is essential for developing new therapeutic strategies targeting senescence evasion.
• Further research into JMJD3's intersection with cancer pathways and SASP is warranted.